LSP closes European life sciences fund at USD600m
LSP, a life sciences investor in Europe, has held its final close of LSP 6 at the USD600 million hard cap. This is the largest fund ever raised in Europe focused on life sciences ventures. LSP currently has USD1.1 billion of capital to invest across LSP 6, the LSP Health Economics

